Keith Kaufman, M.D.
NPI 1801240015ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Rahway, NJ
Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in Rahway, New Jersey, licensed in CA, with an NPI issued in April 2016. Regeneron Pharmaceuticals, Inc. was the largest of 2 companies reporting payments in 2025, $1,549 in all, mostly consulting fees.
Overview
| NPI | 1801240015 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | Apr 14, 2016 |
| Last updated in NPPES | Apr 14, 2016 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | G57521 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|
Industry payments (Open Payments)
- 2025$1,549 · 2 payments from 2 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $1,430 | 1 |
| Merck Sharp & Dohme LLC | $119.14 | 1 |
What the 2025 payments were for
- Consulting Fee$1,430 · 1 payment
- Food and Beverage$119.14 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other endocrinologists in Rahway
- 1609997758
- 1891954848